Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital

European Journal of Clinical Pharmacology

Volumn 70, Issue 12, 2014, Pages 1519-1526

  Durrieu, G ^a,b   Batz, A ^a,b   Rousseau, V ^a,b   Bondon Guitton, E ^a,b   Petiot, D ^a   Montastruc, J L ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adverse drug reaction reporting systems; Databases; Pediatrics; Pharmacovigilance

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADVERSE DRUG REACTION; ARTICLE; CHILD; DATA BASE; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HOSPITAL PATIENT; HUMAN; ICD-10; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICALIZATION; NEWBORN; PEDIATRIC HOSPITAL; UNIVERSITY HOSPITAL; FACTUAL DATABASE; HOSPITAL; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FRANCE; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; MALE; PHARMACOVIGILANCE;

EID: 84919951833     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1763-1     Document Type: Article

References (30)

1. Aagaard L, Christensen A, Hansen EH (2010) Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 70:481-491
2. Choonara I (2013) Educational paper: aspects of clinical pharmacology in children (2013) pharmacovigilance and safety. Eur J Pediatr 172:577-580
3. Gallagher R, Mason J, Bird K, Kirkham J, Peak M, Williamsom P, Nunn A, Turner M, Pirmohamed M, Smyth R (2012) Adverse drug reactions causing admission to a paediatric hospital. PloS One 7:e50127
4. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77-83
5. Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, Williamson P (2012) Adverse drug reactions in children - a systematic review. PloS One 7:1-24
6. Johann-Liang R, Wyeth J, Chen M, Cope J (2009) Pediatric drug surveillance and the food and drug administration's adverse event reporting system: an overview of reports, 2003-2007. Pharmacoepidemiol Drug Saf 18:24-27
7. Autret-Leca E, Marchand MS, Cissokoa H, Beau-Salinas F, Jonville-Bera AP (2012) Pharmacovigilance in children. Arch Pediatr 19:848-855
8. Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54(6):665-670
9. Milne CP, Davis J (2014) The pediatric studies initiative: after 15 years have we reached the limits of the law? Clin Ther 95(1):98-109
10. Haslund-Krog S, Mathiasen R, Christensen HR, Holst H (2014) The impact of legislation on drug substances used off-label in paediatric wards - a nationwide study. Eur J Clin Pharmacol 70(4):448-452
11. Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 33:327-339
12. Miguel A, Azevedo LF, Lopes F, Freitas A et al (2013) Methodologies for the detection of adverse drug reactions: comparison of hospital databases, charts review and spontaneous reporting. Pharmacoepidemiol Drug Saf 22:98-102
13. Martin-Latry K, Bégaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19:256-265
14. Neubert A, Doormann H, Weiss J, Criegge-Rieck M, Ackermann A, Levy M, Brune K, Rasher W (2006) Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 62:959-965
15. Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC, TEDDY Network of Excellence (2008) Databases for pediatric medicine research in Europe-assessment and critical appraisal. Pharmacoepidemiol Drug Saf 17:1155-1167
16. Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G (2003) Detecting adverse events using information technology. J Am Med Inform Assoc 10:115-128
17. Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 63:221-228
18. Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M (2006) Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br J Clin Pharmacol 62:225-231
19. Begaud B, Evreux JC, Jouglard J, Lagier G (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40:111-118
20. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255-1259
21. Gallay A, Nardonnel A, Vaillant V, Desenclos JC (2002) The capture-recapture applied to epidemiology: principles, limits and application. Rev Epidemiol Sante Publique 50:219-232
22. Weill A, Païta M, Tuppin P, Fagot JP, Neumann A, Simon D, Ricordeau P, Montastruc JL, Allemand H (2010) Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. Pharmacoepidemiol Drug Saf 19:1256-1262
23. Couffignal AL, Lapeyre-Mestre M, Bonhomme C, Bugat R, Montastruc JL (2000) Adverse effects of anticancer drugs: a propos of a pharmacovigilance study at a specialized oncology institution. Therapie 55:635-641
24. Jouanjus E, Leymarie F, Tubery M, Lapeyre-Mestre M (2011) Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol 71:758-765
25. Jouanjus E, Pourcel L, Saivin S, Molinier L, Lapeyre-Mestre M (2012) Use of multiple sources and capture-recapture method to estimate the frequency of hospitalizations related to drug abuse. Pharmacoepidemiol Drug Saf 21:733-741
26. Daveluy A, Miremont-Salamé G, Kostrzewa A, Couret A, Lacoin L, Lecomte C, Moore N, Gilleron V, Haramburu F (2012) Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiol Drug Saf 21:1344-1349
27. Seiber EE (2007) Physician code creep: evidence in Medicaid and State Employee Health Insurance billing. Health Care Financ Rev 28:83-93
28. Cox AR, Anton C, Goh CHF, Easter M, Langford NJ, Ferner RE (2001) Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol 52:337-339
29. Lapeyre-Mestre M, Gary J, Machelard-Roumagnac M, Bonhomme C, Bugat R, Montastruc JL (1997) Incidence and cost of adverse drug reactions in a French cancer institute. Eur J Clin Pharmacol 53:19-22
30. Salmeron-Garcia A, Cabeza Barrera J, Vergara Pavon MJ et al (2012) Detection of adverse drug reactions through the minimum basic data set. Pharm World Sci 32:322-328